Admission Date:  [**2180-7-24**]              Discharge Date:   [**2180-7-29**]  Date of Birth:  [**2107-5-20**]             Sex:   F  Service: [**Hospital Unit Name 196**]  Allergies: [**Doctor First Name **]  Attending:[**First Name3 (LF) 2704**] Chief Complaint: Chest Pain  Major Surgical or Invasive Procedure: Cardiac catherization  History of Present Illness: HPI: 73 female with CAD s/p LAD stent [**72**], DM2, hyperlipidemia, CRI, metastatic liposarcoma of thigh who presented with L sided CP constant nonradiating and s/p fall out of bed landing on R side.
LAD and LCX treated with balloon PTCA and stenting (Cypher).
Final LAD residual was 10% with normal flow and LCX no residual with normal flow.
Previous echo on [**5-2**] showed EF>55%  Past Medical History: Coronary artery disease s/p MI, PCI to LAD ([**2172**]) L thigh liposarcoma s/p radiation, metastases to lungs DM hypercholesterolemia CRI Chest/Back pain from metastases colonic polyp s/p partial colectomy GERD s/p CCY, partial TAH  Social History: Married with one son.
Family History: Mother with DM, HTN Brother with [**Name2 (NI) 499**] CA  Physical Exam: T: afebrile HR 90 BP 118/65 Gen: Pt in discomfort due to pain in leg Heent: PERRLA, EOMI, oral mucosa clear Neck: no JVD Lungs: CTA B/L CV: RRR, S1/S2 no murmur, no carotid bruits Abd: NABS NTND Groin: R femoral cath site, no bruit or hematoma Ext: no edema   Pertinent Results: [**2180-7-25**] 12:00AM   CK(CPK)-265* [**2180-7-25**] 12:00AM   CK-MB-25* MB INDX-9.4* cTropnT-3.55* [**2180-7-25**] 12:00AM   WBC-7.0 RBC-3.94* HGB-9.3* HCT-30.9* MCV-79* MCH-23.7* MCHC-30.2* RDW-15.7* [**2180-7-25**] 12:00AM   PLT COUNT-234 [**2180-7-24**] 03:40PM   POTASSIUM-4.9 [**2180-7-24**] 03:40PM   CK(CPK)-548* [**2180-7-24**] 03:40PM   CK-MB-59* MB INDX-10.8* [**2180-7-24**] 03:40PM   PLT COUNT-213 [**2180-7-24**] 10:11AM   PLT COUNT-202 [**2180-7-24**] 08:28AM   TYPE-ART O2 FLOW-3 PO2-75* PCO2-40 PH-7.37 TOTAL CO2-24 BASE XS--1 INTUBATED-INTUBATED COMMENTS-NASAL [**Last Name (un) 154**] [**2180-7-24**] 08:28AM   HGB-8.1* calcHCT-24 O2 SAT-95 [**2180-7-24**] 07:11AM   PT-12.5 PTT-22.5 INR(PT)-1.0 [**2180-7-24**] 06:50AM   GLUCOSE-172* UREA N-36* CREAT-1.1 SODIUM-139 POTASSIUM-3.5 CHLORIDE-102 TOTAL CO2-24 ANION GAP-17 [**2180-7-24**] 06:50AM   CK(CPK)-20* [**2180-7-24**] 06:50AM   CK-MB-NotDone [**2180-7-24**] 06:50AM   WBC-7.2# RBC-3.67* HGB-8.5* HCT-28.2* MCV-77* MCH-23.3* MCHC-30.4* RDW-15.5 [**2180-7-24**] 06:50AM   CALCIUM-9.7 PHOSPHATE-3.7 MAGNESIUM-1.8 [**2180-7-24**] 06:50AM   NEUTS-60.5 LYMPHS-26.0 MONOS-5.7 EOS-6.8* BASOS-1.1 [**2180-7-24**] 06:50AM   HYPOCHROM-3+ MICROCYT-1+ [**2180-7-24**] 06:50AM   PLT COUNT-176  Echo [**2180-7-24**] 1.The left atrium is normal in size.
4.The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic regurgitation.
She has known CAD and had an LAD stent placed on [**2173-10-31**].
Percutaneous coronary revascularization was performed using placement of drug-eluting stent(s).
Percutaneous coronary revascularization of an additional vessel was performed using placement of drug-eluting stent(s).
RESISTANCE 92  **% SATURATION DATA (NL) PA MAIN 55 AO 91 **ARTERIAL BLOOD GAS pO2 75 pCO2 40 pH 7.37  OTHER HEMODYNAMIC DATA:      The oxygen consumption was assumed.
FROM **LEFT CORONARY 5) LEFT MAIN   NORMAL 6) PROXIMAL LAD   NORMAL 6A) SEPTAL-1   NORMAL 7) MID-LAD   DISCRETE 90 8) DISTAL LAD   DIFFUSELY DISEASED 9) DIAGONAL-1   NORMAL 10) DIAGONAL-2   DIFFUSELY DISEASED 12) PROXIMAL CX   DISCRETE 60 13) MID CX   NORMAL 13A) DISTAL CX   NORMAL 14) OBTUSE MARGINAL-1   NORMAL 15) OBTUSE MARGINAL-2   NORMAL 16) OBTUSE MARGINAL-3   NORMAL   **PTCA RESULTS   LAD CX **BASELINE STENOSIS PRE-PTCA [**65**] 60 **TECHNIQUE PTCA SEQUENCE 1 1 GUIDING CATH 8FXB3.5 8FXB3.5 GUIDEWIRES FORTE FORTE INITIAL BALLOON (mm) 2.0 3.0 FINAL BALLOON (mm) 2.75 3.75 # INFLATIONS 3 2 MAX PRESSURE (PSI) 310 310 **RESULT STENOSIS POST-PTCA [**85**] 10 SUCCESS?
We decided to treat both these lesions with baloon PTCA and stenting.
The lesion was crossed with a Fortte wire without difficulty.
The stent was then postdilated with a 3.75xx8mm Quanrum Maverick baloon inflated at 22 atms.
Contrast:           Non-ionic low osmolar (isovue, optiray...), vol 225 ml  Premedications:           ASA 325 mg P.O.
Anticoagulation:           Heparin 4000 units IV Other medication:           Fentanyl 125mcg IV           Midazolam 1.5mg IV           Integrilin 6.2cc IV           Integrilin 11cc/h IV           TNG 100mcg IC           Plavix 600mg PO Cardiac Cath Supplies Used:           .014 [**Company **], FORTE MS           .014 [**Name (NI) **], PT [**Name (NI) **], 300CM           2.0 GUIDANT, VOYAGER 15           2.75 [**Company **], QUANTUM MAVERICK, 15           3.75 [**Company **], QUANTUM MAVERICK, 8           8F CORDIS, XBLAD 3.5           200CC MALLINCRODT, OPTIRAY 200CC           2.5 CORDIS, CYPHER RX, 18           3.5 CORDIS, CYPHER RX, 13   COMMENTS: 1.
The previously placed LAD stent was widely patent.
Successful stenting of the mid LAD with a 2.5x18mm Cypher DES  postdilated to 2.75mm (See PTCA comments).
Successful stenting of the proximal LCX with a 3.0x13mm Cypher [**Name Prefix (Prefixes) **] [**Last Name (Prefixes) 7930**] to 3.75mm (See PTCA comments).-  FINAL DIAGNOSIS: 1.
Acute anterolateral MI treated with PCI/stenting of the mid LAD using Drug Eluting Stent.
Successful stenting of the proximal LCX using Drug Eluting Stent.
Pt was started on [**Name (NI) 30474**] and ACEI, but medication was held after pt became hypotensive.
Pain service was consulted and pt was first given oxycontin and IV morphine which was switched to oxycontin and MSIR for breakthrough pain.
Xray of right hip was done to r/o fracture, xray came back negative.
Pt was given fluids and Cre and urine output monitored.
Medications on Admission: Oxycontin 30 [**Hospital1 **]; MS-IR 15mg 1-2prn; ASA 325mg; atenolol/chlorthalidone 100/25, Lipitor 10, Celebrex 100mg, glipizide 5mg, lisinopril 40mg, protonix 40mg  Discharge Medications: 1.
Aspirin 325 mg Tablet, Delayed Release (E.C.)
Clopidogrel Bisulfate 75 mg Tablet Sig: One (1) Tablet PO QD (once a day).
Morphine Sulfate 15 mg Tablet Sig: One (1) Tablet PO Q2-3H (every 2-3 hours) as needed for for breakthrough pain: Please call your primary care physician for refill.
Oxycodone HCl 40 mg Tablet Sustained Release 12HR Sig: One (1) Tablet Sustained Release 12HR PO BID (2 times a day): Please call your PCP for refill.
Disp:*20 Tablet Sustained Release 12HR(s)* Refills:*0* 5.
Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.)
Senna 8.6 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day) as needed for constipation.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Atorvastatin Calcium 10 mg Tablet Sig: One (1) Tablet PO once a day.
Glipizide 5 mg Tablet Sig: One (1) Tablet PO once a day.
Nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1) Sublingual q5 minutes x 3 prn as needed for chest pain: please take one pill under your tongue [**Doctor First Name **] 5 minutes, do not exceed 3 pills.
You are being treated with medications after your heart attack.
It is important that you continue to take Plavix and Asprin everyday until you are told to stop by your cardiologist.
Please do not take Celebrex with Aspirin and Plavix.
Please take all medications as prescribed.
Please consult your primary care physician [**Last Name (NamePattern4) **] [**2180-8-1**] regarding whether you need to resume your blood pressure medicines.
